BCPC
BALCHEM CORP
Nasdaq · CIK 9326
Last close166.56
Daily change+2.87 (1.75%)
10 Years gain+120.59%
Dividends TTM0.96 (+10.34%)
Dividend yield0.59%
Fundamental Analysis
BCPC · STANDARD
SIC 2800 · Chemicals & Allied Products · Fiscal year end 1231
Fundamental
68.6Momentum
n/aAcceleration
n/aConfidence
77.0Annual Revenue17
Quarterly Revenue81
Annual CFO16
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth8.9 / 25
Quality18.8 / 25
Capital Efficiency13.7 / 20
Balance Sheet15.0 / 15
Shareholder Economics8.8 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 0.4932 percentage points.
Share count reductionDiluted share count declined 1.4748%.
Key Metrics
Revenue Growth TTM10.14%OK
Revenue CAGR 3Y3.25%OK
Gross Margin36.29%OK
Operating Marginn/aMISSING
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-1.47%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $1.04B | $370.63M | $209.33M | $216.56M | n/a | 35.74% | 20.18% | n/a | 14.49% | 32.6M |
| 2025 FY Dec 31, 2024 | $953.68M | $336.21M | $182.91M | $182.00M | n/a | 35.25% | 19.18% | n/a | 13.83% | 32.72M |
| 2025 FY Dec 31, 2023 | $922.44M | $302.06M | $159.19M | $183.76M | n/a | 32.75% | 17.26% | n/a | 13.51% | 32.45M |
| 2024 FY Dec 31, 2022 | $942.36M | $280.45M | $145.19M | $138.54M | n/a | 29.76% | 15.41% | n/a | 13.94% | 32.39M |
| 2023 FY Dec 31, 2021 | $799.02M | $243.17M | $127.50M | $160.51M | n/a | 30.43% | 15.96% | n/a | 13.28% | 32.67M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $1.09B | sum latest 4 fiscal quarters Revenue | OK | 0000009326-26-000007, 0000009326-26-000018 |
| Revenue Growth TTM | 10.14% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000009326-26-000007, 0000009326-26-000018 |
| Revenue CAGR 3Y | 3.25% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000009326-26-000007 |
| Revenue CAGR 5Y | 8.07% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000009326-26-000007 |
| Gross Profit CAGR 3Y | 9.74% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000009326-26-000007 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 36.29% | Gross Profit / Revenue | OK | 0000009326-26-000007, 0000009326-26-000018 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000009326-26-000028 |
| Current Ratio | 2.66x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $33.72 | Revenue / Diluted Shares | OK | 0000009326-26-000007, 0000009326-26-000018 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | 18.27% | Cash dividends paid / Net income | OK | 0000009326-26-000007 |
| Diluted EPS TTM | n/a | Net income TTM / Diluted shares | NOT_MEANINGFUL | 0000009326-26-000028 |